Research indicates that controlling weight aids in broader disease control for those with a chronic condition like Type 2 diabetes [1]
That's because there's been little other help: obesity doctors New data also shows a reduced rate of cardiovascular problems in some patients Despite widely publicized reports of rare but severe side effects, obesity doctors say Ozempic and drugs like it have the potential to improve medical help for a chronic illness that patients have been forced for too long to try to cure on their own
For your next dose, just make sure to stick to a fatty tissue area, like your abdomen, thigh, or upper arm
Common risk factors for NAION include: Diabetes High blood pressure High cholesterol Sleep apnea Small or crowded optic nerves Smoking Cardiovascular disease Older age These risk factors are important because many patients who take GLP-1 medications may already have diabetes, obesity, sleep apnea, or vascular risk factors that can also increase NAION risk
Short-term time-restricted feeding is safe and feasible in non-obese healthy midlife and older adults
Serious adverse effects are rare but occur at a higher rate than with placebo